Objective:To observe the efficacy of Yin-tonifying Ophiopogonis Decoction combined with Rehabilitation New Liquid in the treatment of reflux esophagitis(RE).Methods:Seventy-four patients with RE were included in the s...Objective:To observe the efficacy of Yin-tonifying Ophiopogonis Decoction combined with Rehabilitation New Liquid in the treatment of reflux esophagitis(RE).Methods:Seventy-four patients with RE were included in the study and they were divided into an observation group and a control group using the random number table method with 37 cases in each group.The patients in the control group were given oral Yin-tonifying Ophiopogonis Decoction whereas the patients in the observation group were additionally treated with the Rehabilitation New Liquid.The clinical efficacy,traditional Chinese medicine(TCM)symptoms,and the efficiency of gastroscopy were compared between the two groups.Results:The total effective rate of clinical symptoms,TCM symptoms,and gastroscopy results between the observation group and the control group were significantly different(P<0.05)and were statistically significant.Conclusion:The clinical effect ofYin-tonifying Ophiopogonis Decoction combined with the Rehabilitation New Liquid in the treatment of RE is significant.展开更多
目的:以中药为原料,研制一种治疗反流性食管炎(RE)的颗粒剂,并进行临床疗效观察。方法:正源颗粒由代赭石、柴胡、黄连、吴茱萸、白术、枳壳、半夏、延胡索等药物组成。采用水提醇沉法提取有效成分,与适宜辅料制成颗粒剂。将224例符合纳...目的:以中药为原料,研制一种治疗反流性食管炎(RE)的颗粒剂,并进行临床疗效观察。方法:正源颗粒由代赭石、柴胡、黄连、吴茱萸、白术、枳壳、半夏、延胡索等药物组成。采用水提醇沉法提取有效成分,与适宜辅料制成颗粒剂。将224例符合纳入标准的RE患者按随机原则分为两组。治疗组113例,口服正源颗粒15 g,每日3次;对照组111例,口服奥美拉唑20 m g、每日2次,西沙必利5 m g、每日3次;两组均服药6周。进行治疗前后临床疗效、胃镜下RE分级和积分评价。结果:治疗组和对照组患者临床症状均能明显改善。经临床治疗,治疗组近期(6周)疗效与对照组比较差异无显著性(P>0.05)。但远期(1年)疗效比较治疗组总有效率(72.6%)显著高于对照组(54.9%),差异有显著性(P<0.01),治疗组以其较低的复发率(18.8%)优于对照组(31.5%),两组比较差异有显著性(P<0.05),且无不良反应发生。结论:正源颗粒剂型选择得当,制备工艺简单,质量稳定,疗效确切,使用方便,值得临床推广。展开更多
文摘Objective:To observe the efficacy of Yin-tonifying Ophiopogonis Decoction combined with Rehabilitation New Liquid in the treatment of reflux esophagitis(RE).Methods:Seventy-four patients with RE were included in the study and they were divided into an observation group and a control group using the random number table method with 37 cases in each group.The patients in the control group were given oral Yin-tonifying Ophiopogonis Decoction whereas the patients in the observation group were additionally treated with the Rehabilitation New Liquid.The clinical efficacy,traditional Chinese medicine(TCM)symptoms,and the efficiency of gastroscopy were compared between the two groups.Results:The total effective rate of clinical symptoms,TCM symptoms,and gastroscopy results between the observation group and the control group were significantly different(P<0.05)and were statistically significant.Conclusion:The clinical effect ofYin-tonifying Ophiopogonis Decoction combined with the Rehabilitation New Liquid in the treatment of RE is significant.
文摘目的:以中药为原料,研制一种治疗反流性食管炎(RE)的颗粒剂,并进行临床疗效观察。方法:正源颗粒由代赭石、柴胡、黄连、吴茱萸、白术、枳壳、半夏、延胡索等药物组成。采用水提醇沉法提取有效成分,与适宜辅料制成颗粒剂。将224例符合纳入标准的RE患者按随机原则分为两组。治疗组113例,口服正源颗粒15 g,每日3次;对照组111例,口服奥美拉唑20 m g、每日2次,西沙必利5 m g、每日3次;两组均服药6周。进行治疗前后临床疗效、胃镜下RE分级和积分评价。结果:治疗组和对照组患者临床症状均能明显改善。经临床治疗,治疗组近期(6周)疗效与对照组比较差异无显著性(P>0.05)。但远期(1年)疗效比较治疗组总有效率(72.6%)显著高于对照组(54.9%),差异有显著性(P<0.01),治疗组以其较低的复发率(18.8%)优于对照组(31.5%),两组比较差异有显著性(P<0.05),且无不良反应发生。结论:正源颗粒剂型选择得当,制备工艺简单,质量稳定,疗效确切,使用方便,值得临床推广。